Pharmacogenomics and Stratified Healthcare

Module overview

Genetic variants that affect drug targets or drug metabolising enzymes can determine whether or not a patient may respond to a particular drug, or experience toxicity. Genomic information provides unprecedented opportunities to tailor drug treatment to the patient. You will learn the underlying mechanisms for genetic variation in drug response; about examples of drug development for specific targets altered in some cancers; and the practicalities of validating stratified or personalised medicine approaches in clinical trials.

Credits

15 Masters level credits

Module attendance required

Teaching delivered one day each week for five consecutive weeks.

Module dates

First iteration -  starts on 5 September for 5 consecutive Fridays
Second iteration - starts on 9 January for 5 consecutive Fridays

Assessment

The module will be assessed via a short presentation, a 3000-word essay assignment and short-answer/case study problems completed in your own time.  For those taking the module as a stand-alone option, you need only take the assessment if you require the University credits.

Academics involved in the delivery of this module 

Module Lead:
Professor Gary Middleton (Professor of Medical Oncology, University of Birmingham and Honorary Consultant Medical Oncologist)
And Professor Mary Keen (University of Birmingham)

Other University staff teaching:
Dr Jamie Coleman
Dr Nick Hodges
Professor Cindy Billingham
Mrs Karen Doyle
Professor Tim Barrett

NHS staff teaching:
Dr Philippe Taniere
Dr Rachel Webster

Interested in taking this individual module as a CPD programme?

This module can be taken as a standalone assessed or non-assessed course.  Costs to be confirmed.  

You should have a good honours degree in a life sciences subject, although we will consider applicants with alternative qualifications and professional experience within the health service or other relevant background. You should either take module 1 (An Introduction to Human Genetics and Genomics), module 2 (Omics Techniques and their Application to Genomic Medicine) and module 4 (Genomics in Cancer Pathology) first, or be able to show you have equivalent knowledge and understanding to enable you to benefit from this module. 

Please contact the Programme Administrator for further information. 

Dr Peter F. Searle
Email: p.f.searle@bham.ac.uk  
Tel: +44 (0)121 414 4487